SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-066974
Filing Date
2018-11-08
Accepted
2018-11-08 16:16:36
Documents
67
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-19033_110q.htm 10-Q 1290491
2 EX-31.1 a18-19033_1ex31d1.htm EX-31.1 12619
3 EX-31.2 a18-19033_1ex31d2.htm EX-31.2 12618
4 EX-32.1 a18-19033_1ex32d1.htm EX-32.1 5452
5 EX-32.2 a18-19033_1ex32d2.htm EX-32.2 5457
  Complete submission text file 0001104659-18-066974.txt   6633305

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT stml-20180930.xml EX-101.INS 1743037
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stml-20180930.xsd EX-101.SCH 48187
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stml-20180930_cal.xml EX-101.CAL 49815
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stml-20180930_def.xml EX-101.DEF 147132
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT stml-20180930_lab.xml EX-101.LAB 436094
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stml-20180930_pre.xml EX-101.PRE 292136
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35619 | Film No.: 181169875
SIC: 2834 Pharmaceutical Preparations